The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLitigation Cap. Regulatory News (LIT)

Share Price Information for Litigation Cap. (LIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 117.00
Bid: 116.50
Ask: 118.00
Change: -0.50 (-0.43%)
Spread: 1.50 (1.288%)
Open: 116.50
High: 118.00
Low: 116.50
Prev. Close: 117.50
LIT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conclusion of Joint Venture Arrangement

20 Apr 2020 07:00

RNS Number : 1634K
Litigation Capital Management Ltd
20 April 2020
 

20 April 2020

 

 

Litigation Capital Management Limited

(LCM or the Company)

 

 

Conclusion of Joint Venture Arrangement

 

Litigation Capital Management Limited (AIM:LIT), a leading international provider of disputes financing solutions, announces the conclusion of its Joint Venture Arrangement (JVA or Arrangement) with Vannin Capital Limited (Vannin) and associated profit of A$2.45 million.

 

In 2013, LCM entered into a JVA with Vannin. That JVA involved LCM sourcing, negotiating and managing through to completion various litigation finance investments, all within Australia. Vannin supplied the capital associated with the Arrangement. In March 2015, the Arrangement went into runoff.

 

Whilst in runoff, certain disputes arose between the parties as to their entitlements. As part of the final resolution of those disputes, LCM will receive profits totalling A$2.45 million, contributing to LCM's gross profit for the current financial year. The JVA has now been concluded by all interested parties.

Patrick Moloney, CEO of LCM, commented: "We are very pleased to have come to a final resolution of the Joint Venture Arrangement, the amount received from which, exceeds our expectations."

 

Enquiries

 

Litigation Capital Management

c/o Alma PR 

Patrick Moloney, Chief Executive Officer

Canaccord (Nomad and Joint Broker) 

Tel: 020 7523 8000

Bobbie Hilliam

Investec Bank plc (Joint Broker)

Tel: 020 7597 5970

David Anderson

Alma PR

Tel: 020 3405 0205

Rebecca Sanders-Hewett

LCM@almapr.co.uk

Justine James

David Ison

 

 

NOTES TO EDITORS

 

Litigation Capital Management (LCM) is a global provider of disputes finance which operates two business models. The first is direct investments made from LCM's permanent balance sheet capital and the second is fund and/or asset management. Under those two business models, LCM currently pursues three investment strategies: Single-case funding, Corporate portfolio funding and Acquisitions of claims. LCM generates its revenue from both its direct investments and also performance fees through asset management.

LCM has an unparalleled track record, driven by effective project selection, active project management and robust risk management.

 

Headquartered in Sydney, with offices in London, Singapore, Brisbane and Melbourne, LCM listed on AIM in December 2018, trading under the ticker LIT.

 

www.lcmfinance.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
JVEIMMATMTATMIM
Date   Source Headline
22nd May 20204:36 pmRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSConclusion of Joint Venture Arrangement
3rd Apr 20207:08 amRNSManagement Update and Corporate Reorganisation
24th Mar 20207:00 amRNSFinal closure of US$150 million fund
23rd Mar 20207:41 amRNSDirector/PDMR Shareholding
17th Mar 20207:00 amRNSHalf-year Report
10th Mar 20207:00 amRNSFirst close of a new US$150 million fund
13th Feb 20207:00 amRNSNotice of Results
6th Feb 202012:07 pmRNSSecond Price Monitoring Extn
6th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Dec 20198:04 amRNSCase Investment Settlement Update
16th Dec 20194:41 pmRNSSecond Price Monitoring Extn
16th Dec 20194:35 pmRNSPrice Monitoring Extension
11th Dec 201912:07 pmRNSSecond Price Monitoring Extn
11th Dec 201912:02 pmRNSPrice Monitoring Extension
10th Dec 20197:00 amRNSCapital Markets Event and Third-Party Fund Update
2nd Dec 20197:00 amRNSNotice of Dividend Currency Exchange Rate
21st Nov 20199:30 amRNSHolding(s) in Company
21st Nov 20198:25 amRNSResult of AGM
18th Nov 201912:23 pmRNS2019 Annual Report & Accounts
12th Nov 201912:07 pmRNSSecond Price Monitoring Extn
12th Nov 201912:02 pmRNSPrice Monitoring Extension
6th Nov 20197:00 amRNSAppointment of Joint Broker
1st Nov 201911:23 amRNSIncentive Awards
16th Oct 20198:00 amRNSNotice of Annual General Meeting
30th Sep 201912:00 pmRNSHolding(s) in Company
30th Sep 201912:00 pmRNSHolding(s) in Company
13th Sep 20193:01 pmRNSHolding(s) in Company
10th Sep 20197:00 amRNSFinal Results
2nd Sep 20197:30 amRNSNotice of Results
17th Jul 201910:42 amRNSHolding(s) in Company
28th Jun 201911:44 amRNSConditional Settlement of Litigation Project
13th Jun 20197:00 amRNSFunding of Corporate Portfolio Transaction
3rd Jun 20198:59 amRNSNotice of Dividend Currency Exchange Rate
28th May 20197:42 amRNSCourt Approval Settlement and Pipeline Update
8th Apr 201910:14 amRNSHolding(s) in Company
5th Apr 201912:18 pmRNSHolding(s) in Company
1st Apr 20199:00 amRNSTotal Voting Rights
28th Mar 20191:32 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSGlobal cooperation agreement with law firm
20th Mar 20199:56 amRNSSettlement in principle of litigation project
8th Mar 20197:00 amRNSJSOP Award
7th Mar 20195:08 pmRNSAppointment of Jonathan Moulds as Chairman
4th Mar 20197:00 amRNSHalf-year Report
20th Feb 20198:00 amRNSNotice of Results
18th Feb 201912:05 pmRNSHolding(s) in Company
15th Feb 20197:00 amRNSHolding(s) in Company
6th Feb 201910:44 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSNew litigation project
21st Dec 20181:08 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.